Navigation Links
BioMaxx Systems Inc. Signs Engagement Letter With Alcofuel Technologies for Provision of an Ethanol Micro-Refinery

TORONTO, Aug. 15 /PRNewswire-FirstCall/ -- BioMaxx Systems Inc. (Other OTC: BMXSF), is pleased to announce it has signed an engagement letter with Alcofuel Technologies Ltd., for the provision of the design, manufacture and installation of an ethanol micro-refinery. Pursuant to the engagement letter, Alcofuel Technologies has agreed, subject to the terms and conditions of the engagement letter, to design and manufacture a small scale ethanol micro-refinery capable of producing 30,000 litres of ethanol per day. The micro-refinery will be capable of processing fuel grade ethanol from a variety of feed-stocks indigenous to Asia, such as Cassava, Sweet Sorghum and cellulosic biomass.

It is the intention of BioMaxx Systems Inc., to locate the ethanol micro- refinery in our Thailand demonstration facility and utilize waste by-products from our bio-diesel production facility to produce inexpensive ethanol alcohols.

BioMaxx Systems has chosen Alcofuel Technologies based on their extensive experience in the ethanol production industry and their access to proprietary ethanol production process technologies.

About BioMaxx Systems Inc.

BioMaxx Systems is a biotechnology consulting company that focuses on the development of innovative technology solutions to address our dependence on fossil fuels. The company develops technologies to produce clean fuels such as Ethanol and Hydrogen and promotes clean, efficient alternatives that reduce harmful carbon dioxide emissions and Green House Gases.

BioMaxx Systems Inc. provides professional consulting services in the fields of biotechnology, bio-fuels, renewable energy and related specializations. BioMaxx will leverage the knowledge of our experienced professionals and consultants with distinct specializations in the key areas of biotechnology and bio-energy. BioMaxx Systems Inc. is a Canadian company with international reach, covering most global markets.

Safe Harbor Statement:

This release includes forward looking statements, which are based on certain assumptions and reflects management's current expectations. These forward looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. The Company disclaims any intention or obligation to update or revise any forward looking statements, whether as a result of new information, future events or otherwise.

SOURCE BioMaxx Systems Inc.

Copyright©2007 PR Newswire.

Related biology technology :

1. Assess the In Vivo Activation of Signal Transduction Pathways with PathDetect Reporting Systems
2. prostar RT-PCR Systems for Robust High-Fidelity RNA Amplification
3. Performance Comparisons of Commercial RT-PCR Systems
4. Signal Transduction Reporting Systems Using Cis-Acting Enhancer Elements
5. In Vivo Signal Transduction Pathway Reporting Systems
6. Improved Vectors for PathDetect Trans-Reporting Systems
7. Genetic Reporter Systems
8. Genetic Reporter Systems
9. Matched siRNAs and Assays: Ambion + Applied Biosystems = RNAi Success
10. Separation Reproducibility With the BioLogic Chromatography Systems
11. Preparative SDS-PAGE Electrophoresis of a Recombinant Epstein-Barr Virus Encoded Protein and Its Application in Serodiagnostic Test Systems, Rev C
Post Your Comments:
(Date:6/23/2016)... , June 23, 2016   EpiBiome , ... secured $1 million in debt financing from Silicon Valley ... up automation and to advance its drug development efforts, ... new facility. "SVB has been an incredible ... the services a traditional bank would provide," said Dr. ...
(Date:6/23/2016)... 23, 2016 Apellis Pharmaceuticals, Inc. today ... trials of its complement C3 inhibitor, APL-2. The ... ascending dose studies designed to assess the safety, ... injection in healthy adult volunteers. Forty ... a single dose (ranging from 45 to 1,440mg) ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, ... Pennsylvania Convention Center and will showcase its product’s latest features from June 26 ... presenting a scientific poster on Disrupting Clinical Trials in The Cloud during the ...
(Date:6/23/2016)... adds 2016 global ... pharmaceuticals section with historic and forecast data along ... Complete report on the Cell Culture ... companies and supported with 261 tables and figures ... The Global Cell Culture Media Industry ...
Breaking Biology Technology:
(Date:4/26/2016)... and LONDON , ... Finacle, part of EdgeVerve Systems, a product subsidiary ... Onegini today announced a partnership to integrate the ...      (Logo: ) ... provide their customers enhanced security to access and ...
(Date:4/15/2016)... Research and Markets has announced ... 2016-2020,"  report to their offering.  , ... global gait biometrics market is expected to grow ... 2016-2020. Gait analysis generates multiple variables ... to compute factors that are not or cannot ...
(Date:3/31/2016)...  Genomics firm Nabsys has completed a financial  restructuring ... , M.D., who returned to the company in October ... team, including Chief Technology Officer, John Oliver , ... and Vice President of Software and Informatics, Michael ... Dr. Bready served as CEO of Nabsys from 2005-2014 ...
Breaking Biology News(10 mins):